B
SRNE

Baird’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Baird’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$3.29M Sell
284,132
-60,141
-17% -$696K 0.03% 428
2014
Q4 		$3.47M Buy
344,273
+2,153
+0.6% +$10.9K 0.04% 424
2014
Q3 		$1.55M Buy
342,120
+130,827
+62% +$703K 0.02% 527
2014
Q2 		$1.43M Buy
211,293
+142,670
+208% +$1.08M 0.02% 577
2014
Q1 		$880K Buy
+68,623
New +$759K 0.01% 668

Other funds holding SRNE

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Baird's SRNE Position: Q1 2015 in Review

Baird reduced its Sorrento Therapeutics, Inc. (SRNE) stake by 17% in Q1 2015, selling an estimated $696K and leaving 284,132 shares worth $3.29M. The position accounts for 0.03% of the portfolio, ranked #428.

Baird first reported a position in SRNE in Q1 2014 and has held it in 5 quarters since. The position peaked at $3.47M in Q4 2014. 56 funds tracked by Wall St. Rank hold SRNE as of Q1 2015.

  • Baird held 284,132 shares of Sorrento Therapeutics, Inc. worth $3.29M as of Q1 2015.
  • Baird sold 60,141 Sorrento Therapeutics, Inc. shares in Q1 2015, an estimated $696K.
  • Sorrento Therapeutics, Inc. made up 0.03% of Baird's portfolio in Q1 2015, its #428 holding.
  • Baird first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and has held it in 5 quarters since.
  • Baird's Sorrento Therapeutics, Inc. position peaked at $3.47M in Q4 2014.
  • 56 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.